Why Moderna, Inc. (MRNA) stock is gloomy today?
Moderna, Inc. (MRNA) stock announced third quarter 2021 financial results after which it became bearish today. MRNA stock saw a downtrend of 15.86% to drop
Moderna, Inc. (MRNA) stock announced third quarter 2021 financial results after which it became bearish today. MRNA stock saw a downtrend of 15.86% to drop
In a news release on Monday, Moderna Inc. (MRNA) announced that Dr. Paul Burton would be taking over as head of the medical department as
AstraZeneca (AZN), a British drug company, sold 1.2 billion dollars worth of its shares in Moderna (mRNA). With 7.7% of the shares, the company was
Copyright©2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.